MacroGenics Announces Date of Fourth Quarter and Full Year 2014 Financial Results Conference Call
MacroGenics, Inc. (Nasdaq: MGNX) today announced that on
Tuesday, March 3, 2015, the Company will release its financial
results for the fourth quarter and full year 2014. The Company's
management team will host a conference call discussing the
Company's financial results and recent corporate developments on
Tuesday, March 3, 2015 at 4:30 pm (EDT). The call can be accessed
by dialing (877) 303-6253 (domestic) or (973) 409-9610
(international) five minutes prior to the start of the call and
providing the passcode 92691132.
The recorded, listen-only webcast of the conference call can be
accessed under "Events & Presentations" in the Investor
Relations section of the Company's website at http://ir.macrogenics.com/events.cfm. A replay
of the webcast will be available shortly after the conclusion of
the call and archived on the Company's website for 30 days
following the call.
About MacroGenics, Inc.
MacroGenics is a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal
antibody-based therapeutics for the treatment of cancer, as well as
autoimmune disorders and infectious diseases. The company generates
its pipeline of product candidates from its proprietary suite of
next-generation antibody-based technology platforms. The
combination of MacroGenics' technology platforms and protein
engineering expertise has allowed the Company to generate promising
product candidates and enter into several strategic collaborations
with global pharmaceutical and biotechnology companies. For more
information, please see the Company's website at
www.macrogenics.com. MacroGenics is a registered
trademark of MacroGenics, Inc.
Jim Karrels, Senior Vice President, CFO
Karen Sharma, Vice President
MacDougall Biomedical Communications
Source: MacroGenics, Inc.
News Provided by Acquire Media